Originally Posted by
trader_jackson
Unfortunately I cannot help some emotion creep into my posts on this thread, particularly in recent times (and I openly admit this)...
It is because some of the users on here simply do not seem to have given PEB much of a chance, and have completely discounted it before any meaningful results (good or bad) have even been provided from the all important user programmes, and eventually the sales that may or may not occur - this being the most crucial "result". Not one of the substantial user programmes have yet to be concluded (and therefore sales cannot be evaluated), so to say PEB have "failed" and "not delivered" (from a sales point of view) is rubbish, once again not giving management a chance to prove their sales skills, just like initially, some years back, nobody gave them a chance to prove the science of their product (again writing PEB off) until many medical journals/doctors etc begun to say "hey this actually works"... now everyone on here has gone from "PEB's product doesn't work" to "PEB's product is great", will the same happen with regards to commercialisation/sales? That is yet to be seen and cannot be judged right now...(I have suggested waiting at least 2 years, while watching the announcements as they come, until "judgement day")...anyone judging managements progress in terms of sales now is "jumping the gun" as I have said several times (in several different ways)
I agree that there will need to be some updates between now and 2 years time (I never meant for there to be no update during this period), but to start judging if PEB has been a commercial success (or not) now is extremely premature.
(also, Franko, I wasn't sure on how long PEB have been commercial.. and merely referencing anther post, and I believe you if it is 2011... I would call 45 years a long time, but I wouldn't call 4.5 years a long time "in anyones book")
... I do very much enjoy this discussion and look forward to hearing the several reasons why I SHOULD start judging if PEB has been a commercial success or not (other than the "additional" capital raising "technicality")